Survey of physical activity and quality of life for people with fibromuscular dysplasia
National Survey of Physical Activity Restrictions and Quality of Life Among Patients With Fibromuscular Dysplasia
This national survey asks adults with fibromuscular dysplasia to see if activity restrictions affect their quality of life and emotional well-being.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT07529691 on ClinicalTrials.gov |
What this trial studies
This observational study will deliver an electronic REDCap survey to adults who self-identify as having fibromuscular dysplasia to document the types of physical activity recommendations they received and how those recommendations affect daily life and emotions. The survey targets a broad, national population of English-speaking participants aged 18–100 and collects information on activity limits, counseling sources, and quality-of-life impacts. Because current guidance is based largely on expert opinion and varies across providers, the study aims to map real-world advice and its consequences for patients. Results will summarize the breadth of recommendations and their reported effects to inform future guidance and patient counseling.
Who should consider this trial
Good fit: Adults aged 18–100 with a diagnosis of fibromuscular dysplasia who can read English and complete an online survey are ideal candidates.
Not a fit: People who cannot complete electronic consent or the online survey, non-English speakers, or those without a diagnosis of FMD are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the findings could clarify common activity recommendations and support better counseling to improve quality of life for people with FMD.
How similar studies have performed: This approach is largely novel for FMD at a national scale, as existing guidance is expert opinion and there have been no large national surveys characterizing activity recommendations and their impacts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Participants with a diagnosis of fibromuscular dysplasia * Age range = 18-100 years Exclusion Criteria: * Subjects who have an inability to complete the electronic consent form or electronic survey for any reason * Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey
Where this trial is running
Nashville, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Study coordinator: Amanda Morrison, MD
- Email: amanda.morrison@vumc.org
- Phone: 615-322-5000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.